Angiogenesis is a key function of vascular endothelial cells, and becomes aberrant in pathologies like preeclampsia. An important mediator of angiogenesis is vascular endothelial growth factor (VEGF) receptor FLT1; however, alternative splicing of FLT1 can generate soluble FLT1 (sFLT1), a decoy receptor that inhibits VEGF signaling. While some long non-coding RNAs (lncRNAs) are known to regulate splicing, their roles in endothelial biology remain poorly defined. Here, we identify lncRNA LINC00607 as a critical regulator of FLT1 alternative splicing. Loss of LINC00607 increased the formation of the anti-angiogenic sFLT1. CRISPR-mediated knockout of LINC00607 promoted exon 15 inclusion in FLT1, elevating sFLT1 levels and blunting VEGF-driven angiogenesis -a defect reversed by sFLT1-neutralizing antibodies. LINC00607 interacted with U2 snRNA to regulate exon 15 inclusion in FLT1, an interaction dependent on the chromatin-remodeler BRG1. A splice-blocking morpholino targeting the FLT1 intron14/exon15 junction specifically inhibited sFLT1 production by interacting with LINC00607 and U2 snRNA, and its application increased VEGF-A-mediated sprouting. LINC00607 expression inversely correlated with sFLT1 levels in vascular diseases. In preeclampsia, a multisystem pregnancy disorder involving hypertension and proteinuria, LINC00607 was downregulated in early and late-stage preeclampsia compared to healthy pregnancies. LINC00607 therefore fine-tunes VEGF signaling and might contribute to the pathophysiology of preeclampsia.
Building similarity graph...
Analyzing shared references across papers
Loading...
Frederike Lam
Timothy Warwick
James A. Oo
Molecular Therapy
Goethe University Frankfurt
Humboldt-Universität zu Berlin
Maastricht University Medical Centre
Building similarity graph...
Analyzing shared references across papers
Loading...
Lam et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d5efd374eaea4b11a795ea — DOI: https://doi.org/10.1016/j.ymthe.2026.03.038